None
Quote | Bemis Company Inc. (NYSE:BMS)
Last: | $ |
---|---|
Change Percent: | 0.00% |
Open: | $N/A |
Close: | $57.25 |
High: | $N/A |
Low: | $N/A |
Volume: | 0 |
Last Trade Date Time: | 06/12/2019 09:32:17 am |
News | Bemis Company Inc. (NYSE:BMS)
K36 Therapeutics Announces Presentation on KTX-1001 for Relapsed and Refractory Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting PR Newswire Poster to be presented Sunday, December 10, 2023 CAMBRIDGE, Mass. , Dec. 4, 2023 /PRNe...
Excellent dividend stocks are great to hold in times of economic downturns. Since the best of the best typically don't suspend -- or even reduce -- their dividend payments regardless of market and economic conditions, the regular and predictable dividend payments can help investors smooth o...
Message Board Posts | Bemis Company Inc. (NYSE:BMS)
Subject | By | Source | When |
---|---|---|---|
Bemis Company Reports Solid Fourth Quarter and 2018 Results | fuzzy | investorshub | 01/31/2019 11:20:24 AM |
News: $BMS Update on Amcor and Bemis Transaction | whytestocks | investorshub | 01/24/2019 12:04:30 PM |
Press Release: Update on Amcor and Bemis Transaction | fuzzy | investorshub | 01/24/2019 11:13:18 AM |
NEENAH, Wis.--(BUSINESS WIRE)-- | fuzzy | investorshub | 11/01/2018 8:23:38 PM |
Bemis Shareholders Upset Over Merger Bid and Seek | tedkov | investorshub | 08/16/2018 9:55:16 PM |
News, Short Squeeze, Breakout and More Instantly...
Bemis Company Inc. Company Name:
BMS Stock Symbol:
NYSE Market:
K36 Therapeutics Announces Presentation on KTX-1001 for Relapsed and Refractory Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting PR Newswire Poster to be presented Sunday, December 10, 2023 CAMBRIDGE, Mass. , Dec. 4, 2023 /PRNe...
Excellent dividend stocks are great to hold in times of economic downturns. Since the best of the best typically don't suspend -- or even reduce -- their dividend payments regardless of market and economic conditions, the regular and predictable dividend payments can help investors smooth o...
Exelixis (NASDAQ: EXEL) and bluebird bio (NASDAQ: BLUE) are two biotech companies that have been moving in opposite directions on the stock market this year. While Exelixis has provided healthy gains -- its stock is up by 52.1% year to date -- Bluebird's shares have slid by 35.2% since t...